Skip to main content
Hansoh Pharmaceutical Group Company Limited (HNSPF)
OTCMKTS · Delayed Price · Currency is USD
2.700
0.00 (0.00%)
Jun 6, 2025, 4:00 PM EDT

Revenue by Product

Fiscal year is January - December.
Year Ending
 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 NaN - NaN
Oncology
6.82B
Log In
Log In
Log In
Log In
Upgrade
Oncology Growth
6.16%
Log In
Log In
Log In
Log In
Upgrade
Central Nervous System Diseases
1.51B
Log In
Log In
Log In
Log In
Upgrade
Central Nervous System Diseases Growth
-13.05%
Log In
Log In
Log In
Log In
Upgrade
Metabolic Diseases and Others
1.44B
Log In
Log In
Log In
Log In
Upgrade
Metabolic Diseases and Others Growth
10.51%
Log In
Log In
Log In
Log In
Upgrade
Anti-infective Diseases
1.40B
Log In
Log In
Log In
Log In
Upgrade
Anti-infective Diseases Growth
-3.46%
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Fiscal year is January - December.
Year Ending
 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 NaN - NaN
China
11.16B
Log In
Log In
Log In
Log In
Upgrade
China Growth
2.33%
Log In
Log In
Log In
Log In
Upgrade